Previous 10 | Next 10 |
TOKYO and MIAMI, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Pfizer Japan Inc. and OPKO Health, Inc. (NASDAQ: OPK) announced today that the next generation long-acting growth hormone injection, NGENLA ® (somatrogon) Inj. 24 mg Pens and 60 mg Pens, has been approved by the Ministry of Health,...
Trading Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks and blue chips here and in full effect, there is a lot for investors to keep track of. While volatility remains extremely high right now, having a consistent understanding of the lat...
Business combination projected to deliver $350 million in pro forma 2022 revenue $200 million private placement from leading growth and life sciences investors, including Pfizer, will fortify transaction and Sema4 balance sheet Katherine Stueland, CEO of GeneDx and forme...
OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 40 th Annual J.P. Morgan Healthcare Conference being held virtually January 10-13, 2022. Management will be hosting one-on-one meetings with investors and will be participating in a virt...
3 Penny Stocks to Add to Your Watchlist Right Now With 2021 ending just as quickly as it started, penny stocks continue to show potential. Although the last few weeks have been quite up and down as a result of the Omicron variant, in the past day or two, we’ve seen renewed bullis...
OPKO Health's (NASDAQ:OPK) Rayaldee, which works to increase vitamin D levels, met its primary endpoint based on top-line data from a phase 2 trial of COVID-19 outpatients. By day 7, mean serum vitamin D levels increased with Rayaldee to 82 ng/mL and remained elevated for length of the t...
MIAMI, Dec. 23, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces preliminary topline results from its Phase 2 trial with RAYALDEE ® to treat mild-to-moderate COVID-19. This study builds on increasing medical evidence that vitamin D repletion therapy can mitiga...
The company's revenue over the past 12 months amounted to about $1.87 billion, an increase of 30.2% compared to 2020. OPKO Health's net debt was about $95.7 million in Q3 2021, down 60.4% from a year earlier and 48.2% down from Q2 2021. In Q4 2021, OPKO Health, in partnership with...
Are you looking for penny stocks to buy right now? Let’s see what analysts have to say. Believe it or not, market analysts don’t solely cover higher-priced stocks like Apple or Netflix. Among the hundreds of companies with shares trading below the $5 threshold, some firms foll...
3 Penny Stocks to Watch in December 2021 If you’re making a list of the best penny stocks to buy, there are hundreds of options to choose from. Before beginning to make a penny stocks watchlist , it’s best to understand what’s going on in the market. Right now, ...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...